Healthcare Insights

Stakeholder Education: Partnering for Rare Success

By Jenna Riffell on Mar 21, 2019 4:33:02 PM

In this second installment of Kaiser's rare disease blog series, we explore the importance of stakeholder education in rare disease drug development. Read more on how companies can effectively work with key stakeholders in the rare disease space to better meet the needs of the patient population and succeed in the market.

Read More

Topics: Insights, Rare diseases, Pharmaceuticals, Gene therapy, Commercial growth, Strategy

An Orphan Journey: Commercializing Rare Disease Drugs

By Sean Vander Linde on Feb 13, 2019 3:37:48 PM

In this series, Kaiser will explore how rare disease companies can develop commercial growth strategies to succeed against the challenges of a high cost and highly specialized market.

2018 saw 91 orphan drug approvals by the FDA – nearly 3 times greater than in 2013 and the highest number of approvals yet – along with over 400 designations for the candidates in development [1]. 2019 is expected to bring even more approvals as more companies begin to realize R&D investments in rare diseases. Driven by high pricing potential, significant unmet needs, and favorable regulatory policy, orphan drug sales are expected to balloon to reach $262B in the next 5 years [2]. The market continues to grow more competitive and new technologies are emerging, such as Spark Therapeutics’ Luxturna, which marks the first FDA approval in a new class of one-time gene therapy treatments targeting inherited diseases. In this environment, companies will need to shift their focus to how they can play strategically and optimize the value of their orphan therapies. 

Read More

Topics: Insights, Rare diseases, Pharmaceuticals, Gene therapy, Commercial growth, Strategy

Recent Articles

About Kaiser's Healthcare Insights

Kaiser's Healthcare Insights blog shares company expertise on hot market trends, behaviors, and news that are shaping the global healthcare space. These posts share commercial growth strategies and tactics for leading pharmaceutical, medical device, and health IT companies to drive top-line growth and a unique competitive advantage within their respective spaces.

This blog is updated regularly so check back in for our latest perspectives on healthcare trends or sign up to receive updates right in your inbox.

Contact Us

Learn more about Kaiser’s Healthcare Practice.